| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 105, 1722-1727, Copyright © 1994 by American College of Chest Physicians
ARTICLES |
M Ip, K Lam, L Yam, A Kung and M Ng
Department of Medicine, University of Hong Kong, Queen Mary Hospital.
Inhaled corticosteroids have become a key element in the maintenance treatment of bronchial asthma. It is well-known that long-term systemic steroid use causes osteoporosis, whereas its inhaled counterpart has been believed to be devoid of such a side-effect. However, recent studies showed that administration of inhaled corticosteroids was associated with biochemical evidence of derangement in bone turnover. We therefore studied bone mineral density (BMD) by dual energy x-ray absorptiometry in 30 patients (18 females, 12 males) with bronchial asthma treated with steroids, essentially by the inhaled route only (both nasal and tracheobronchial), and compared them with healthy subjects individually matched for age, sex, menopausal status, and body mass index (BMI). There was a significant decrease in BMD in the patient group at the hip (neck of femur, p = 0.007; trochanter of femur, p = 0.034; Ward's triangle, p = 0.016) and the lumbar area of the spine (L2-4, p = 0.041). Further analysis showed that this difference from control subjects was mainly seen in the female patients and not in the male patients (neck of femur, p = 0.049; Ward's triangle, p = 0.025; lumbar spine, p = 0.039). In the female patients, there was significant negative correlation of BMD of the lumbar area of the spine and the trochanter of femur with daily inhaled steroid dose and positive correlation of BMD of the trochanter with BMI.
This article has been cited by other articles:
|
|
 |
|
  M. P. Heffernan, K. G. Saag, J. K. Robinson, and J. P. Callen Prevention of Osteoporosis Associated With Chronic Glucocorticoid Therapy JAMA, March 15, 2006; 295(11): 1300 - 1303. [Full Text] [PDF]
|
|
|
|
 |
|
 B. T. Summey and G. Yosipovitch Glucocorticoid-Induced Bone Loss in Dermatologic Patients: An Update Arch Dermatol, January 1, 2006; 142(1): 82 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Schlienger, S. S. Jick, and C. R. Meier Inhaled Corticosteroids and the Risk of Fractures in Children and Adolescents Pediatrics, August 1, 2004; 114(2): 469 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Lee and K. B. Weiss Fracture Risk Associated with Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 855 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Suissa, M. Baltzan, R. Kremer, and P. Ernst Inhaled and Nasal Corticosteroid Use and the Risk of Fracture Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 83 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. England, J. S. Nugent, K. W. Grathwohl, L. Hagan, and J. M. Quinn High-Dose Inhaled Fluticasone and Delayed Hypersensitivity Skin Testing Chest, April 1, 2003; 123(4): 1014 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Sharma, S. Malhotra, P. Pandhi, and N. Kumar Effect of Inhaled Steroids on Bone Mineral Density: A Meta-Analysis J. Clin. Pharmacol., February 1, 2003; 43(2): 193 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. F. Dubois, E. Roder, P. N. R. Dekhuijzen, A. E. Zwinderman, and D. H. Schweitzer Dual Energy X-ray Absorptiometry Outcomes in Male COPD Patients After Treatment With Different Glucocorticoid Regimens* Chest, May 1, 2002; 121(5): 1456 - 1463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Biskobing COPD and Osteoporosis Chest, February 1, 2002; 121(2): 609 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Matsumoto, K. Ishihara, T. Hasegawa, B.-i. Umeda, A. Niimi, and M. Hino Effects of Inhaled Corticosteroid and Short Courses of Oral Corticosteroids on Bone Mineral Density in Asthmatic Patients : A 4-Year Longitudinal Study Chest, November 1, 2001; 120(5): 1468 - 1473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Israel, T. R. Banerjee, G. M. Fitzmaurice, T. V. Kotlov, K. LaHive, and M. S. LeBoff Effects of Inhaled Glucocorticoids on Bone Density in Premenopausal Women N. Engl. J. Med., September 27, 2001; 345(13): 941 - 947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Chapman, D. P. Tashkin, and D. J. Pye Gender Bias in the Diagnosis of COPD Chest, June 1, 2001; 119(6): 1691 - 1695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Patterson-Buckendahl, M. Rusnak, K. Fukuhara, and R. Kvetnansky Repeated immobilization stress reduces rat vertebral bone growth and osteocalcin Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R79 - R86. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T C Medici, E Grebski, M Häcki, P Rüegsegger, C Maden, and J Efthimiou Effect of one year treatment with inhaled fluticasone propionate or beclomethasone dipropionate on bone density and bone metabolism: a randomised parallel group study in adult asthmatic subjects Thorax, May 1, 2000; 55(5): 375 - 382. [Abstract] [Full Text]
|
|
|
|
|
|
M. F. Goldstein, J. J. Fallon Jr, and R. Harning Chronic Glucocorticoid Therapy-Induced Osteoporosis in Patients With Obstructive Lung Disease* Chest, December 1, 1999; 116(6): 1733 - 1749. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Lipworth Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis Arch Intern Med, May 10, 1999; 159(9): 941 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. LAATIKAINEN, H. P. J. KROGER, H. O. TUKIAINEN, R. J. HONKANEN, and S. V. SAARIKOSKI Bone Mineral Density in Perimenopausal Women with Asthma . A Population-based Cross-sectional Study Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): 1179 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-P. BOULET, J. MILOT, L. GAGNON, P. E. POUBELLE, and J. BROWN Long-Term Influence of Inhaled Corticosteroids on Bone Metabolism and Density . Are Biological Markers Predictors of Bone Loss? Am. J. Respir. Crit. Care Med., March 1, 1999; 159(3): 838 - 844. [Abstract] [Full Text]
|
|
|
|
|
|
J A Hughes, B G Conry, S M Male, and R Eastell One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density Thorax, March 1, 1999; 54(3): 223 - 229. [Abstract] [Full Text]
|
|
|
|
|
|
K. Nishimura, H. Koyama, A. Ikeda, M. Tsukino, T. Hajiro, M. Mishima, and T. Izumi The Effect of High-Dose Inhaled Beclomethasone Dipropionate in Patients With Stable COPD Chest, January 1, 1999; 115(1): 31 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. PAUWELS, J. C. YERNAULT, M. G. DEMEDTS, and P. GEUSENS Safety and Efficacy of Fluticasone and Beclomethasone in Moderate to Severe Asthma Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 827 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Cumming, P. Mitchell, and S. R. Leeder Use of Inhaled Corticosteroids and the Risk of Cataracts N. Engl. J. Med., July 3, 1997; 337(1): 8 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Barnes Inhaled Glucocorticoids for Asthma N. Engl. J. Med., March 30, 1995; 332(13): 868 - 875. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
